Two years' outcome of acute mania in bipolar disorder: Different effects of age and age of onset

International Journal of Geriatric Psychiatry

Volumn 30, Issue 2, 2015, Pages 201-209

  Oostervink, Frits ^a   Nolen, Willem A ^b   Kok, Rob M ^c  

^a GGZ Haagstreek ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c PARNASSIA PSYCHIATRIC INSTITUTE   (Netherlands)

Author keywords

Age of onset; Bipolar disorder; Older; Outcome; Therapeutics

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; HYPNOTIC AGENT; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE;

ADULT; AGE DISTRIBUTION; ARTICLE; BIPOLAR I DISORDER; BIPOLAR MANIA; CONTROLLED STUDY; DELUSION; FOLLOW UP; HALLUCINATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MIDDLE AGED; MIXED MANIA AND DEPRESSION; ONSET AGE; OUTCOME ASSESSMENT; RECURRENT DISEASE; RELAPSE; REMISSION; SHORT COURSE THERAPY; ACUTE DISEASE; AGE; AGED; BIPOLAR DISORDER; FEMALE; MALE; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

ACUTE DISEASE; ADULT; AGE FACTORS; AGE OF ONSET; AGED; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES;

EID: 84921022441     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.4128     Document Type: Article

References (64)

1. Aizenberg D, Olmer A, Barak Y. 2006. Suicide attempts amongst elderly bipolar patients. J Affect Disord 91: 91-94.
2. Almeida OP, Fenner S. 2002. Bipolar disorder: similarities and differences between patients with illness onset before and after 65 years of age. Int Psychogeriatr 14: 311-322.
3. American Psychiatric Association. 2002. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 159: 1-50.
4. BALANCE Investigators and Collaborators. 2010. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder: a randomised open-label trial. Lancet 375: 385-396.
5. Besga A, Martinez-Cengotitabengoa M, González-Ortega I, et al. 2011. The role of white matter damage in late onset bipolar disorder. Maturitas 70: 160-163.
6. Beyer JL, Burchitt B, Gersing K, et al. 2008. Patterns of pharmacotherapy and treatment response in elderly adults with bipolar disorder. Psychopharmacol Bull 41: 102-114.
7. Chu D, Gildengers AG, Houck PR, et al. 2010. Does age at onset have clinical significance in older adults with bipolar disorder? Int J Geriatr Psychiatry 25: 1266-1271.
8. Clayton PJ. 1983. The prevalence and course of the affective disorders. In The Affective Disorders, Davis J, Maas J (eds.). APP: Washington, DC; 193-201.
9. Cruz LP, Miranda PM, Vedana KG, et al. 2011. Medication therapy: adherence, knowledge and difficulties of elderly people from bipolar disorder. Rev Latino-Am Enfermagem 19: 944-952.
10. D'Souza R, Rajji TK, Mulsant BH, Pollock BG. 2011. Use of lithium in the treatment of bipolar disorder in late-life. Curr Psychiatry Rep 13: 488-492.
11. Degenhardt EK, Gatz JL, Jacob J, et al. 2012. Predictors of relapse or recurrence in bipolar I disorder. J Affect Disord 136: 733-739.
12. Depp CA, Jeste DV. 2004. Bipolar disorder in elderly adults: a critical review. Bipolar Disord 6: 343-367.
13. Depp CA, Lebowitz BD. 2007. Enhancing medication adherence in older adults with bipolar disorder. Psychiatry 6: 22-32.
14. Depp CA, Cain AE, Palmer BW, et al. 2008. Assessment of medication management ability in middle-aged and older adults with bipolar disorder. J Clin Psychopharmacol 28: 225-229.
15. Dunbar-Jacob J, Mortimer-Stephens MK. 2001. Treatment adherence in chronic disease. J Clin Epidemiol 54(Suppl 1): S57-60.
16. Fortney JC, Pyne JM, Edlund MJ, et al. 2011. Reasons for antidepressant nonadherence among veterans treated in primary care clinics. J Clin Psychiatry 72: 827-834.
17. Fried TR, Tinetti ME, Towle V, et al. 2011. Effects of bene fits and harms on older persons' willingness to take medication for primary cardiovascular prevention. Arch Intern Med 171: 923-928.
18. Gajwani P. 2009. Treatment-refractory bipolar disorder: classification to aid in clinical management. Expert Opin Pharmacother 10: 1907-1915.
19. Geoffroy PA, Etain B, Scott J, et al. 2013 Reconsideration of bipolar disorder as a developmental disorder: importance of the time of onset. J Physiol Paris 107: 278-285.
20. Goetz I, Tohen M, Reed C, et al. 2007. Functional impairment in patients with mania: baseline results of the EMBLEM study. Bipolar Disord 9: 45-52.
21. Gonzalez-Pinto AM, Dardennes R, de Zélicourt M, et al. 2010. In-patient care costs of patients with bipolar I disorder: a comparison between two European centers. J Affect Disord 121: 152-155.
22. Goodwin GM, Consensus Group of the British Association for Psychopharmacology. 2009. Evidence-based guidelines for treating bipolar disorder: revised second edition - recommendations from the British Association for Psychopharmacology. J Psychopharmacol 23: 346-388.
23. Goodwin FK, Jamison KR (eds.). 2007. Manic-depressive Illness: Bipolar Disorders and Recurrent Depression, 2nd edn. Oxford University Press: New York.
24. Grunze H, Goetz I, Gonzalez-Pinto A, et al. 2004. Pharmacological treatment of acute mania in Europe: EMBLEM baseline findings. Acta Psychiatr Scand 110(S423): 20(P22)
25. Gunde E, Blagdon R, Hajek T. 2011. White matter hyperintensities: from medical comorbidities to bipolar disorders and back. Ann Medicine 43: 571-580.
26. Haro JM, Reed C, Gonzalez-Pinto A, et al. 2011. 2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery. Eur Neuropsychopharm 21: 287-293.
27. Haro JM, Van Os J, Vieta E, et al. 2006. Evidence for three distinct classes of 'typical', 'psychotic ' and 'dual ' mania: results from the EMBLEM study. Acta Psychiatr Scand 113: 112-120.
28. Jurdi RK, Marangell LB, Petersen NJ, et al. 2008. Prescription patterns of psychotropic medications in elderly compared with younger participants who achieved a 'recovered ' status in the systematic treatment enhancement program for bipolar disorder. Am J Geriatr Psychiatry 16: 922-33.
29. Jurdi RK, Nguyen QX, Petersen NJ, et al. 2012. Acute bipolar I affective episode presentation across life span. J Geriatr Psychiatry Neurol 25: 6-14.
30. Kessing LV. 2006. Diagnostic subtypes of bipolar disorder in older versus younger adults. Bipolar Disord 8: 56-64.
31. Ketter TA. 2008. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder. J Clin Psychiatry 69(Suppl 5): 9-15.
32. Lala SV, Sajatovic M. 2012. Medical and psychiatric comorbidities among elderly individuals with bipolar disorder: a literature review. J Geriatr Psychiatry Neurol 25: 20-25.
33. Lehmann SW, Rabins PV. 2000. Factors related to hospitalization in elderly manic patients with early and late-onset bipolar disorder. Int J Geriatr Psychiatry 21: 1060-1064.
34. Maj M. 2000. The impact of lithium prophylaxis on the course of bipolar disorder: a review of the research evidence. Bipolar Disord 2: 93-101.
35. McHorney CA, Spain CV. 2011. Frequency of and reasons for medication nonfulfillment and non-persistence among American adults with chronic disease in 2008. Health Expect 14: 307-320.
36. McIntyre RS, Konarski JZ, Soczynska JK, et al. 2006. Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization. Psychiatric Serv 57: 1140-1144.
37. Montes JM, Alegria A, Garcia-Lopez A, et al. 2013. Understanding bipolar disorder in late life clinical and treatment correlates of a sample of elderly outpatients. J Nerv Ment Dis 201: 674-679.
38. Murray E, Hopwood S, Balfour J. 1983. The influence of age on lithium efficacy and side-effects in outpatients. Psychol Med 13: 53-60.
39. NICE clinical guideline 38. 2006. Bipolar disorder: the management of bipolar disorder in adults, children and adolescents, in primary and secondary care. National Institute for Health and Clinical Excellence, London
40. O'Connell RA, Mayo JA, Flatow L, et al. 1991. Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiatry 159: 123-129.
41. Oostervink F, Boomsma MM, Nolen WA. 2009. Bipolar disorder in the elderly; different effects of age and of age of onset. J Affect Disord 116: 176-183.
42. Post RM, Weiss SR. 2011. Tolerance to the prophylactic effects of carbamazepine and related mood stabilizers in the treatment of bipolar disorders. CNS Neurosci Ther 17: 649-660.
43. Post RM, Altshuler LL, Frye MA, et al. 2010. Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. J Clin Psychiatry 71: 1176-1186.
44. Raja M. 2009. Delayed loss of efficacy and depressogenic action of antidepressants. J Clin Psychopharmacol 29: 612-614.
45. Rej S, Butters MA, Aizenstein HJ, et al. 2013. Neuroimaging and neurocognitive abnormalities associated with bipolar disorder in old age. Int J Geriatr Psychiatry. DOI: 10.1002/gps.4021
46. Rosa AR, Cruz N, Franco C, et al. 2010. Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study. J Clin Psychiatry 71: 1000-1006.
47. Sajatovic M, Blow FC (eds.). 2007. Bipolar Disorder in Later Life. The John Hopkins University Press: Baltimore.
48. Sajatovic M, Bingham CR, Campbell EA, et al. 2005a. Bipolar disorder in older adult inpatients. J Nerv Ment Dis 193: 417-419.
49. Sajatovic M, Blow F, Ignacio RV, et al. 2005b. New-onset bipolar disorder in later life. Am J Geriatr Psychiatry 13: 282-289.
50. Sajatovic M, Levin J, Fuentes-Casiano E, et al. 2011. Illness experience and reasons for nonadherence among individuals with bipolar disorder who are poorly adherent with medication. Compr Psychiatry 52: 280-287.
51. Schouws SNTM, Comijs HC, Stek ML, et al. 2009. Cognitive impairment in early and late bipolar disorder. Am J Geriatr Psychiatry 17: 508-515.
52. Shou-Hung H, Shang-Ying T, Jung-Lung H, et al. 2011. Volumetric reduction in various cortical regions of elderly patients with early-onset and late-onset mania. Int Psychogeriatrics 23: 149-154.
53. Shulman KI. 2010. Lithium for older adults with bipolar disorder. Should it still be considered a first-line agent? Drugs Aging 27: 607-615.
54. Snowden MB, Walaszek A, Russo JE, et al. 2004. Geriatric patients improve as much as younger patients from hospitalization on general psychiatric units. J Am Geriatr Soc 52: 1676-1680.
55. Spearing MK, Post RM, Leverich GS, et al. 1997. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 3: 159-171.
56. Tamashiro JH, Zung S, Zanetti MV, et al. 2008. Increased rates of white matter hyperintensities in late-onset bipolar disorder. Bipolar Disord 10: 765-775.
57. Tohen M, Frank E, Bowden FE, et al. 2009. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord 11: 453-473.
58. Tohen M, Vieta E, Gonzalez-Pinto A, et al. 2010. European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) Advisory Board. Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania. J Clin Psychiatry 71: 255-261.
59. Van der Velde CD. 1970. Effectiveness of lithium carbonate in the treatment of manic-depressive illness. Am J Psychiatry 123: 345-351.
60. Weissman MM, Leaf PJ, Tischler GL, et al. 1988. Affective disorders in five United States communities. Psychol Med 18: 141-153.
61. Williams MD, Shah ND, Wagie AE, et al. 2011. Direct costs of bipolar disorder versus other chronic conditions: an employer-based health plan analysis. Psychiatr Serv 62: 1073-1078.
62. Yassa R, Nair NP, Iskander H. 1988. Late-onset bipolar disorder. Psychiatr Clin N Am 11: 117-131.
63. Yatham LN, Kennedy SH, Schaffer A, et al. 2009. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 11: 225-255.
64. Young AH, Rigney U, Shaw S, et al. 2011. Annual cost of managing bipolar disorder to the UK healthcare system. J Affect Disord 133: 450-456.